Related references
Note: Only part of the references are listed.Immune thrombocytopaenic purpura: an autoimmune cross-link between infections and vaccines
M. Rinaldi et al.
LUPUS (2014)
Contemporary management of primary immune thrombocytopenia in adults
S. Lakshmanan et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Successful treatment of severe thrombocytopenia with romiplostim in a pregnant patient with systemic lupus erythematosus
J. K. Alkaabi et al.
LUPUS (2012)
Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort
M. B. Urowitz et al.
ARTHRITIS CARE & RESEARCH (2012)
Eltrombopag, a thrombopoietin-receptor agonist in the treatment of adult chronic immune thrombocytopenia: a review of the efficacy and safety profile
Gregory Cheng
THERAPEUTIC ADVANCES IN HEMATOLOGY (2012)
Eltrombopag: An Oral Thrombopoietin Receptor Agonist for the Treatment of Idiopathic Thrombocytopenic Purpura
Yang Zhang et al.
CLINICAL THERAPEUTICS (2011)
International consensus report on the investigation and management of primary immune thrombocytopenia
Drew Provan et al.
BLOOD (2010)
Risk Factors for Clinical Coronary Heart Disease in Systemic Lupus Erythematosus: The Lupus and Atherosclerosis Evaluation of Risk (LASER) Study
Sahena Haque et al.
JOURNAL OF RHEUMATOLOGY (2010)
The ITP syndrome: pathogenic and clinical diversity
Douglas B. Cines et al.
BLOOD (2009)
Two types of autoantibody-mediated thrombocytopenia in patients with systemic lupus erythematosus
M. Kuwana et al.
RHEUMATOLOGY (2006)
The pathogenesis of immune thrombocytopaenic purpura
N Cooper et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Share Paper
